Developing therapies addressing a multifactorial disease
Endometriosis continues to pose a major clinical and scientific challenge—affecting millions worldwide yet still marked by late diagnoses, limited treatment options, and persistent misconceptions. While its underlying mechanisms span hormonal, immune, and genetic factors, therapeutic innovation has lagged behind. Here, we explore why current approaches fall short and how advanced preclinical platforms are enabling a more targeted, translational path forward.
Ready to advance your endometriosis preclinical development? Download the technical sheet and discover how we help your team move your program.
